Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0002044770-26-000004

Director acquired 2,954 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Goodrich Katherine · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-12 Exercise or conversion : show line 1 in the form +2,954 5,187 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-12 Exercise or conversion : show line 2 in the form Restricted Stock Units −2,954 0 D
Loading xslF345X06/wk-form4_1781640353.xml…